115
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Synovial inflammation analyzed by 3-T magnetic resonance imaging in etanercept-treated patients with rheumatoid arthritis indicates persistent disease activity despite of clinical remission: A pilot study

ORCID Icon, , &
Pages 441-446 | Received 02 Feb 2018, Accepted 18 Apr 2018, Published online: 09 May 2018

References

  • Brook A, Corbett M. Radiographic changes in early rheumatoid disease. Ann Rheum Dis. 1977;36(1):71–3.
  • Schett G, Firestein GS. Mr Outside and Mr inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis. 2010;69:787–9.
  • Wieners G, Detert J, Streitparth F, Pech M, Fischbach F, Burmester G, et al. High-resolution MRI of the wrist and finger joints in patients with rheumatoid arthritis: comparison of 1.5 Tesla and 3.0 Tesla. Eur Radiol. 2007;17(8):2176–82.
  • Østergaard M, Bird P, Gandjbakhch F, Eshed I, Haugen IK, Haavardsholm EA, et al. The OMERACT MRI in arthritis working group – update on status and future research priorities. J Rheumatol. 2015;42(12):2470–2.
  • McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feetsix years later in patients with rheumatoid arthritis. Arthritis Rheum. 2003;48(7):1814–27.
  • Haavardsholm EA, Bøyesen P, Østergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis. 2008;67(6):794–800.
  • Nieuwenhuis WP, van Steenbergen HW, Stomp W, Stijnen T, Huizinga TW, Bloem JL, et al. The course of bone marrow edema in early undifferentiated arthritis and rheumatoid arthritis. Arthritis Rheum. 2016;68(5):1080–8.
  • Rastogi A, Algulin J, Mangat P, Lim AK, Satchithananda K, Hajnal JV, et al. Early metacarpal bone mineral density loss using digital X-ray radiogrammetry and 3-Tesla wrist MRI in established rheumatoid arthritis: a longitudinal one-year observational study. Arthritis. 2015;2015:852989.
  • Conaghan PG, Emery P, Østergaard M, Keystone EC, Genovese MC, Hsia EC, et al. Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial. Ann Rheum Dis. 2011;70(11):1968–74.
  • Døhn UM, Ejbjerg B, Boonen A, Hetland ML, Hansen MS, Knudsen LS, et al. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. Ann Rheum Dis. 2011;70(2):252–8.
  • Conaghan PG, Peterfy C, Olech E, Kaine J, Ridley D, Dicarlo J, et al. The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy. Ann Rheum Dis. 2014;73(5):810–6.
  • Srikhum W, Virayavanich W, Burghardt AJ, Yu A, Link TM, Imboden JB, et al. Quantitative and semiquantitative bone erosion assessment on high-resolution peripheral quantitative computed tomography in rheumatoid arthritis. J Rheumatol. 2013;40(4):408–16.
  • Buchbender C, Ostendorf B, Mattes-György K, Miese F, Wittsack HJ, Quentin M, et al. Synovitis and bone inflammation in early rheumatoid arthritis: high-resolution multi-pinhole SPECT versus MRI. Diagn Interv Radiol. 2013;19(1):20–4.
  • Vordenbäumen S, Schleich C, Lötgers T, Sewerin P, Bleck E, Pauly T, et al. Dynamic contrast-enhanced magnetic resonance imaging of metacarpophalangeal joints reflects histological signs of synovitis in rheumatoid arthritis. Arthritis Res Ther. 2014;16(5):452.
  • Anderson MW, Kaplan PA, Dussault RG, Degnan GG. Magnetic resonance imaging of the wrist. Curr Probl Diagn Radiol. 1998;27(6):187–229.
  • Peterfy CG. MR imaging. Baillieres Clin Rheumatol. 1996;10(4):635–78.
  • Reiser MF, Naegele M. Inflammatory joint disease: static and dynamic gadolinium-enhanced MR imaging. J Magn Reson Imaging. 1993;3:307–10.
  • Østergaard M, Jacobsson LT, Schaufelberger C, Hansen MS, Bijlsma JW, Dudek A, et al. MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16. Ann Rheum Dis. 2015;74(6):1156–63.
  • Suzuki T, Horikoshi M, Sugihara M, Hirota T, Ogishima H, Umeda N, et al. Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI. Mod Rheumatol. 2013;23(4):782–7.
  • Migliore A, Massafra U, Bizzi E, Argento G, Diamanti AP, Germano V, et al. May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study. Eur Rev Med Pharmacol Sci. 2012;16(3):363–9.
  • Lisbona MP, Maymo J, Perich J, Almirall M, Pérez-García C, Carbonell J. Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks. J Rheumatol. 2008;35(3):394–7.
  • Escudero-Vilaplana V, Ramírez-Herraiz E, Trovato-López N, Alañón-Plaza E, Bellini MJ, Herranz-Alonso A, et al. Influence on effectiveness of early treatment with anti-TNF therapy in rheumatoid arthritis. J Pharm Pharm Sci. 2012;15(3):355–60.
  • Seidel MF, Tsalik J, Vetter H, Müller W. Substance P in rheumatic diseases. Curr Rheumatol Rev. 2007;3(1):17–30.
  • Forslind K, Svensson B. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis. Scand J Rheumatol. 2016;45(2):99–102.
  • Krabbe S, Bolce R, Brahe CH, Døhn UM, Ejbjerg BJ, Hetland ML, et al. Investigation of a multi-biomarker disease activity score in rheumatoid arthritis by comparison with magnetic resonance imaging, computed tomography, ultrasonography, and radiography parameters of inflammation and damage. Scand J Rheumatol. 2016;28:1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.